Literature DB >> 8424017

Prader-Willi syndrome: consensus diagnostic criteria.

V A Holm1, S B Cassidy, M G Butler, J M Hanchett, L R Greenswag, B Y Whitman, F Greenberg.   

Abstract

The diagnosis of Prader-Willi syndrome (PWS) is based on clinical findings that change with age. Hypotonia is prominent in infancy. Obesity, mild mental retardation or learning disability, and behavior problems, especially in association with food and eating, result in a debilitating physical and developmental disability in adolescence and adulthood. No consistent biological marker is yet available for PWS in spite of recent research activity in cytogenetics and molecular genetics. Diagnostic criteria for PWS were developed by consensus of seven clinicians experienced with the syndrome in consultation with national and international experts. Two scoring systems are provided: one for children aged 0 to 36 months and another one for children aged 3 years to adults. These criteria will aid in recognition of the syndrome in hypotonic infants and in obese, mildly retarded, behaviorally disturbed adolescents and adults. They will also ensure uniform diagnosis for future clinical and laboratory research in PWS.

Entities:  

Mesh:

Year:  1993        PMID: 8424017      PMCID: PMC6714046     

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  247 in total

Review 1.  Genomic imprinting: implications for human disease.

Authors:  J G Falls; D J Pulford; A A Wylie; R L Jirtle
Journal:  Am J Pathol       Date:  1999-03       Impact factor: 4.307

2.  Hypothalamic expression of snoRNA Snord116 is consistent with a link to the hyperphagia and obesity symptoms of Prader-Willi syndrome.

Authors:  Qian Zhang; Gerrit J Bouma; Kristy McClellan; Stuart Tobet
Journal:  Int J Dev Neurosci       Date:  2012-06-01       Impact factor: 2.457

3.  Counselling dilemmas associated with the molecular characterisation of two Angelman syndrome families.

Authors:  H L Gilbert; J L Buxton; C T Chan; T McKay; S Cottrell; S Ramsden; R M Winter; M E Pembrey; S Malcolm
Journal:  J Med Genet       Date:  1997-08       Impact factor: 6.318

4.  Prader-Willi syndrome in a child with mosaic trisomy 15 and mosaic triplo-X: a molecular analysis.

Authors:  K Devriendt; G Matthijs; S Claes; E Legius; W Proesmans; J J Cassiman; J P Fryns
Journal:  J Med Genet       Date:  1997-04       Impact factor: 6.318

5.  Who are the comorbid adolescents? Agreement between psychiatric diagnosis, youth, parent, and teacher report.

Authors:  Eric A Youngstrom; Robert L Findling; Joseph R Calabrese
Journal:  J Abnorm Child Psychol       Date:  2003-06

6.  Accidental hypothermia in an infant with Prader-Willi syndrome.

Authors:  Toru Watanabe; Haruko Iwabuchi; Masanori Oishi
Journal:  Eur J Pediatr       Date:  2003-06-11       Impact factor: 3.183

7.  Gait patterns in Prader-Willi and Down syndrome patients.

Authors:  Veronica Cimolin; Manuela Galli; Graziano Grugni; Luca Vismara; Giorgio Albertini; Chiara Rigoldi; Paolo Capodaglio
Journal:  J Neuroeng Rehabil       Date:  2010-06-21       Impact factor: 4.262

Review 8.  A Review of the Safety, Efficacy and Mechanisms of Delivery of Nasal Oxytocin in Children: Therapeutic Potential for Autism and Prader-Willi Syndrome, and Recommendations for Future Research.

Authors:  Marilena M DeMayo; Yun Ju C Song; Ian B Hickie; Adam J Guastella
Journal:  Paediatr Drugs       Date:  2017-10       Impact factor: 3.022

9.  Laparoscopic sleeve gastrectomy in 108 obese children and adolescents ages 5 to 21 years by Alqahtani AR, Antonisamy B, Alamri H, Elahmedi M, Zimmerman VA.

Authors:  Ann O Scheimann; Evan E Nadler; Daniel J Driscoll; Merlin G Butler; Jennifer L Miller; Tania P Markovic; Anthony P Goldstone
Journal:  Ann Surg       Date:  2015-04       Impact factor: 12.969

10.  Sudden cardiac death in a child affected by Prader-Willi syndrome.

Authors:  Cristoforo Pomara; Stefano D'Errico; Irene Riezzo; Gian Pio de Cillis; Vittorio Fineschi
Journal:  Int J Legal Med       Date:  2005-03-05       Impact factor: 2.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.